BIOPHEN Heparin Anti-Xa (2 stages)
Chromogenic anti-Xa method for measuring homogeneously heparin in plasma (tested diluted 1:10) or in purified systems, using a two stage method. Offers a wide measurement range from 0 to 1 IU/mL for plasma, or from 0.005 to 0.10 IU/mL for purified systems and is appropriate for testing heparins for their anti-FXa activity. This assay is in compliance with USP Anti-FXa assay for unfractionated heparin.
|SKU ID#||Packaging||Website Links|
|Assay Characteristics||Kit Components||Applications|
|R1: 2x1 mL ATIII |
R2: 2x1 mL FXa
R3: 2x5 mL FXa substrate (SXa-11)
R4: 4x25 mL Reaction buffer
|For the measurement of anti-Xa Heparin activity in research applications. |
This assay, using a predilution of Antithrombin and FXa reagents in R4 buffer, is in compliance with the USP Anti-Factor Xa assay for unfractionated heparin.
Please Note: Results obtained should be for research purposes only and not used for patient diagnosis or treatment.
Streamline Laboratory ProceduresReady-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches.
|Package Inserts||MSDS||Tech Specs||Adaptations|
|BIOPHEN Heparin Anti-Xa - USP/EP ||BIOPHEN Heparin Anti-Xa||BIOPHEN Heparin Anti-Xa||Request Adaptations|